Ana I. Cubas-Atienzar

Limit of detection in different matrices of 19 commercially available rapid antigen tests for the detection of SARS-CoV-2

Ana I. Cubas-Atienzar, Konstantina Kontogianni, Thomas Edwards et al. · Scientific Reports · 2021 · 109 citations · Full text

Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for <i>SARS-CoV-2</i>

Lisa J. Krüger, Mary Gaeddert, Lisa Köppel et al. · 2020 · 85 citations · Full text

Point-of-care Testing, Viral Diagnostics, Diagnosis +20

Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis

Rachel L. Byrne, Grant A. Kay, Konstantina Kontogianni et al. · Emerging infectious diseases · 2020 · 76 citations · Full text

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Saye Khoo, Richard J. Fitzgerald, Geoffrey Saunders et al. · The Lancet Infectious Diseases · 2022 · 76 citations · Full text

Vaccination, Covid-19 Pandemic, Vaccine Trial +8

Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections

Henry M. Staines, Daniela E. Kirwan, David J. Clark et al. · 2020 · 48 citations · Full text

Vaccination, Regular Surveillance, Viral Persistence +14